Pasithea Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -157 | -181 | -161 | -161 |
EBITDA | -10,098 | -2,855 | -3,649 | -3,517 |
EBIT | -10,256 | -3,037 | -3,810 | -3,679 |
Net Income | -10,110 | -3,037 | -3,716 | -3,563 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,396 | -2,890 | -3,868 | -3,055 |
Cash | 55,158,939 | 4,122 | 7,217 | 5,341 |
Basic Shares | 7,031 | 7,444 | 5,641 | 1,096 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $486 | $486 |
Gross Profit | -662 | -649 | -648 | -5 |
EBITDA | -20,194 | -13,600 | -15,330 | -11,722 |
EBIT | -20,857 | -14,249 | -15,979 | -11,727 |
Net Income | -20,427 | -13,904 | -15,961 | -13,936 |
Net Change In Cash | 0 | 0 | 486 | 486 |
Free Cash Flow | -15,211,490 | -13,923 | -13,459 | -13,798 |
Cash | 55,158,939 | 6,922 | 16,331 | 33,087 |
Basic Shares | 7,031 | 1,096 | 1,226 | 1,262 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.89 |
2025-09-30 | -$0.41 |
2025-06-30 | -$0.66 |
2025-03-31 | -$1.61 |
